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Abstract: Background and objectives: The incidence of cutaneous melanoma has been increasing.
Melanoma is an aggressive form of skin cancer irresponsive to radiation and chemotherapy, rendering
this cancer a disease with poor prognosis: In order to surpass some of the limitations addressed
to melanoma treatment, alternatives like vitamins have been investigated. In the present study,
we address this relationship and investigate the possible role of vitamin A. Materials and Methods:
We perform a co-culture assay using a macrophage cell model and RAW 264.7 from mouse, and
also a murine melanoma cell line B16-F10. Macrophages were stimulated with both Escherichia coli
lipopolysaccharides (LPS) as control, and also with LPS plus vitamin A. Results: Using B16-F10 and
RAW 264.7 cell lines, we were able to demonstrate that low concentrations of vitamin A increase
cytotoxic activity of macrophages, whereas higher concentrations have the opposite effect. Conclusion:
These findings can constitute a new point of view related to immunostimulation by nutrients, which
may be considered one major preventive strategy by enhancing the natural defense system of the body.
Keywords: melanoma; oxidative stress; vitamin A; redox modulation; immune response
1. Introduction
Skin cancers represent a major public health problem [1,2]. The incidence of cutaneous melanoma
has increased over the years [3], and it can suppose a clinical and pathological challenge [4,5].
Cutaneous melanoma is a life-threatening skin tumor refractory to available therapies, like radiation
and chemotherapy [5–8].
There are some established risk factors for melanoma development, like family history [9,10],
genetic and hereditary factors, as well as environmental factors [1–3]. Nowadays, nutritional factors
have emerged as possible modifiable risk factors for cutaneous melanoma, since a growing number of
studies have shown that a balanced diet, rich in fruits and vegetables, is associated with lower risks for
several types of cancer, including cutaneous melanoma. These nutrients have also been considered a
possible alternative adjuvants to conventional therapies that are ineffective against this skin cancer
type [1,3].
Vitamin A can be highlighted due to its role in normal and cancer conditions [11–13]. Vitamin A
(retinol) is particularly important, since it cannot be synthesized by animals and, therefore, it must
be supplied from the diet [1,14]. Vitamin A plays an critical role in cell differentiation [1,3], and has
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been demonstrated to inhibit several biological functions including tumor growth, angiogenesis and
metastasis [14,15].
It could also be discussed if vitamin A active metabolites play some role in melanogenesis, but
still this issue has not yet been elucidated [16,17]. The role of melanin pigment in melanoma biology
has been known for several years [18,19]. Melanogenesis, the production of the melanin pigments in
melanocytes, is being considered a molecular therapeutic target for melanoma [20]. Thus, targeting
melanin production may control mutagenesis, promotion, and progression of melanoma [21–23], as
well as enhancing the action of several therapeutic drugs, or even radiation therapy [24,25].
There are some evidences indicating the benefits of vitamin A in cancer therapy. However, the use
of vitamin A for both chemoprevention or even for therapeutic applications remains controversial [1,14].
Accordingly, the main goal of the present study was to create and develop an in vitro model that could
be used to address the use of antioxidant vitamins as therapeutic contributors capable of enhancing
the immune system against cancer. In particular, we wanted to explore the redox effect of vitamin A in
a melanoma cell line (B16-F10), as well as to understand its role in the immune system by assessing the
activation of naïve macrophages (RAW 264.7).
2. Materials and Methods
2.1. Cell Culture
The mouse melanoma B16-F10 cells exhibit in vitro a mixed morphology of spindle-shaped and
epithelial-like cells. It was originally isolated from C57BL/6J mouse strain affected with melanoma.
B16-F10 is a metastatic variant of B16 melanomas with high tropism for lung invasion.
The mouse RAW 264.7 cells exhibit in vitro a morphology of monocyte/macrophage cells and were
originally isolated from Abelson murine leukemia virus-induced tumor of the BALB/c mouse strain.
B16-F10 murine melanoma cell line (ATCC CRL-6475) and RAW 264.7 macrophage-like cell line
(ATCC TIB-71) were maintained in Dulbecco’s modified eagle’s medium (DMEM; Sigma-Aldrich, Saint
Louis, MO, USA). The media formulation was supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Sigma-Aldrich) and 1% penicillin/streptomycin/amphotericin B mixture (Sigma-Aldrich).
Cells were grown at 37 ◦C under a humidified atmosphere with 5% CO2. B16-F10 (104 cells/mL) and
RAW 264.7 (2 × 104 cells/mL) were seeded in 96-wells plates and allowed to adhere for 24 h. Unless
otherwise specified, all treatments and controls were carried out in serum-free conditions [26].
2.2. Dose–Response Assay to H2O2-Induced Oxidative Stress
To determine the accurate hydrogen peroxide (H2O2) concentration to induce oxidative
stress [27,28], B16-F10 malignant melanocytes were treated with different H2O2 concentrations
(10, 25, 50, 75, and 100 µM) for 24 h. The experimental concentration was determined by
thiobarbituric acid reactive substances (TBARS) assay, and cell metabolic activity was measured
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells incubated with
serum-free medium were considered the controls to this experiment (results not shown).
2.3. TBARS Assay
B16-F10 cells (105 cells/mL) were seeded in 24-wells plates and allowed to adhere for 24 h.
Afterwards, melanoma cells were cultured with standard H2O2 treatments in serum-free conditions for
24 h. Then 50% trichloroacetic acid (TCA; Sigma-Aldrich) was added to each treatment. The mixture
was centrifuged (6000 rpm, 2 min, 4 ◦C) and 1% thiobarbituric acid (TBA; Sigma-Aldrich) was added
to the supernatant that was maintained in the water-bath for 40 min. The detection was performed
using the Jenway 6405 UV/Vis spectrophotometer (Felsted, UK) at wavelength absorbance of 535 nm
(results not shown).
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2.4. Dose–Response Assay to Vitamin A
To determine the accurate vitamin A concentration responsible for significant alterations in
cell metabolic activity, B16-F10 malignant melanocytes were incubated with different vitamin A
concentrations (0.1, 1.0, 10.0, and 100.0 µg/mL) for 24 h. Cell metabolic activity was measured by MTT
assay and the experimental concentrations were defined as the lowest value that does not considerably
alter the cell viability, and the highest value that considerably alters the cell viability. Cells incubated
with serum-free medium were considered the controls for this experiment (results not shown).
2.5. Combined Effects of Vitamin A and H2O2
To determine the possible redox effect of vitamin A, B16-F10 malignant melanocytes were
previously submitted to a H2O2 treatment (25 µM) for 24 h. Then B16-F10 cells were submitted to
two different concentrations of vitamin A (0.1 and 100.0 µg/mL) for 24 h. Cell metabolic activity was
measured by MTT assay. Cells incubated with serum-free medium were considered the controls for
this experiment.
2.6. Metabolic Activity Determination: MTT Assay
To measure B16-F10 and RAW 264.7 cell activity, after a 24 h incubation with different treatments,
20 µL of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) (Sigma–Aldrich) was added
into each 96-plate well, followed by a 3 h incubation period. Assays using tetrazolium salts are
generally used to evaluate proliferation and cell viability. Cell proliferation is defined as the cellular
growth rate and cell viability determined by the number of live cells, and is usually expressed as
a percentage of the control [29]. The determination of live cells is generally performed by staining
them with a vital dye under the hemocytometer where it is calculated the number of stained cells
(alive) by the total (stained plus non-stained, or dead). Tetrazolium salts are commonly used as cell
viability measuring methods, which is maybe true, but the accuracy of the expression may be discussed.
Tetrazolium salts are cleaved to formazan by the succinate–tetrazolium reductase system (EC 1.3.99.1)
which belongs to the respiratory chain of the mitochondria, and is only active in metabolically intact
cells. In the present work, we will define the increased reduction of tetrazolium salts to a purple dye as
metabolic activity. Color development was determined by measuring absorbance at 550 nm by Thermo
Electrocorporation Multiskan Ascent® (Shangai, China) microplate reader (data were obtained from
Ascent Software for Multiscan Ascent®, version 2.6) [30].
2.7. Macrophage-Mediated Cytotoxicity
RAW 264.7 macrophage-like cells were incubated with lipopolyssacharides (LPS) from Escherichia
coli O111:B4 (LPS L4391, Sigma–Aldrich) 1000 ng/mL. The activated macrophages were co-incubated
with B16-F10 melanoma cells (10:1 ratio) at 37 ◦C in a 5% CO2 incubator for 24 h. Then cells were
treated with different concentrations of vitamin A (0.1 and 100.0 µg/mL), and the cytotoxic effects of
LPS-activated macrophages–melanoma cells were measured, calculated, and expressed as follows,
were OD stands for optic density for the MTT assay [31]:
% Cytotoxicity = [1 − (OD of (melanoma cells + macrophages) − OD
of macrophages)/(OD of melanoma cells (untreated))] × 100
2.8. Statistical Analysis
The variables were expressed as mean ± SD (standard deviation). Data were analyzed with
GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA). When three or more conditions
were evaluated, statistical analysis was conducted through one-way ANOVA with Sidak post hoc test
for comparisons between control and treatments (H2O2 and vitamin A treatments), and with Tukey’s
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multiple comparisons test for comparisons between every different treatment/condition. Significance
was set at p < 0.05.
3. Results
3.1. Lower Concentrations of Vitamin A May Be Related to Its Possible Antioxidant Properties
After the establishment of a dose versus response curve for the assessment of vitamin A effects
(results not shown), the possible redox effects of the concentration of 0.1 µg/mL were studied.
These results are shown in Figure 1.
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Figure 1. The effect of vitamin A (0.1 µg/mL) in redox modulation on B16-F10 melanoma cells by MTT 
assay. Control (C), H2O2 (25 µM treatment). After 24 h, (0.1 µg/mL) vitamin A was used. C represents 
cells incubated with serum-free medium. Results of metabolic activity of B16-F10 cells represent the 
percentage (%) of treated cells normalized over the absorbance of control, and were represented as 
mean ± SD. The results were statistically significant when p < 0.05. H2O2 decreased the metabolic 
activity of B16-F10 cells when compared to control (p < 0.0001). H2O2 + vitamin A revert the decrease 
of metabolic activity when compared to H2O2 treated cells (p < 0.05). * p < 0.05; **** p < 0.0001. 
Figure 1 compares the cell metabolic activity of the control group to H2O2 treated cells, as well 
as vitamin A treated cells and H2O2 + vitamin A treated cells. Metabolic activity of cells allowed us to 
study viability of the cells on different conditions of treatments. All of these comparisons are 
significant. H2O2 treatments significantly reduce the metabolic activity of melanoma cells (p < 0.0001). 
The same evidence is found in vitamin A treatment (p < 0.05), and in the combined treatment of H2O2 
+ vitamin A (p < 0.05). 
Figure 1 also compares the action of vitamin A in cells treated under oxidative stress caused by 
H2O2. Results demonstrate that 0.1 µg/mL vitamin A may buffer the effect caused by H2O2 (p < 0.05), 
since there is no significant difference between cells treated with vitamin A alone and those treated 
with the vitamin and the same amount of H2O2 (25 µM) that significantly decreases metabolic activity.  
3.2. Higher Concentrations of Vitamin A May Be Related to Its Possible Pro-Oxidant Properties 
The possible redox effects of the concentration of 100 µg/mL were also studied. These results are 
shown in Figure 2. 
Figure 2 compares cell metabolic activity of the control group to H2O2, to vitamin A, and to H2O2 
+ vitamin A treated cells. All of these comparisons are significant. H2O2 (25 µM) treatments 
significantly reduce the metabolic activity of melanoma cells (p < 0.0001), as well as 100 µg/mL 
vitamin A (p < 0.0001) and H2O2 + 100 µg/mL vitamin A treatments (p < 0.0001). Figure 2 also compares 
Figure 1. The effect of vitamin A (0.1 µg/mL) in redox modulation on B16-F10 melanoma cells by MTT
assay. Control (C), H2O2 (25 µM treatment). After 24 h, (0.1 µg/mL) vitamin A was used. C represents
cells incubated with serum-free medium. Results of metabolic activity of B16-F10 cells represent the
percentage (%) of treated cells normalized over the absorbance of control, and were represented as
mean ± SD. The results were statistically significant when p < 0.05. H2O2 decreased the metabolic
activity of B16-F10 cells when compared to control (p < 0.0001). H2O2 + vitamin A revert the decrease
of metabolic activity when co are to 2 treated cells (p < 0.05). * p < 0.05; **** p < 0.0001.
Figure 1 compares the cell etabolic activity of the control group to H2O2 treated cells, as well
as vitamin A treate ll and H2O2 + vitamin A treated cells. Met bolic activity of cells allowed
us o study viability of the cells on different conditions of treatments. All of these comparisons are
significant. H2O2 treat fi tly reduce the metabolic act vity of melanoma cells (p < .0001).
The same evidence i f nd in vitamin A treatment (p < 0.05), and in the combined treatment of
H2O2 + vitamin A (p < 0.05).
Figure 1 also compares the action of vitamin A in cells treated under oxidative stress caused by
H2O2. Results demonstrate that 0.1 µg/mL vitamin A may buffer the effect caused by H2O2 (p < 0.05),
since there is no significant difference between cells treated with vitamin A alone and those treated
with the vitamin and the same amount of H2O2 (25 µM) that significantly decreases metabolic activity.
3.2. Higher Concentrations of Vitamin A May Be Related to Its Possible Pro-Oxidant Properties
The possible redox effects of the concentration of 100 µg/mL were also studied. These results are
shown in Figure 2.
Figure 2 compares cell metabolic activity of the control group to H2O2, to vitamin A, and to
H2O2 + vitamin A treated cells. All of these comparisons are significant. H2O2 (25 µM) treatments
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significantly reduce the metabolic activity of melanoma cells (p < 0.0001), as well as 100 µg/mL vitamin
A (p < 0.0001) and H2O2 + 100 µg/mL vitamin A treatments (p < 0.0001). Figure 2 also compares H2O2
treated cells to vitamin A treated cells and to H2O2 + vitamin A treated cells. All the comparisons
are significant.
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Figure 2. The redox effect vitamin A (100 µg/mL) on metabolic activity of B16-F10 elanoma
cells. H2O2 (25 µM treatment) and vitamin A treatments alone are capable of reducing cell metabolic
activity. However, treatment combination ( 2 2 vitamin A) has a stronger effect on reducing
metabolic activity, which may suggest a possible pro-antioxidant role of vitamin A (100 µg/mL). C
represents cells incubated with serum-free medium. Results represent the percentage (%) of treated cells
normalized over the absorbance of control. and were represented as mean ± SD. * p < 0.05, *** p < 0.001;
**** p < 0.0001.
When comparing H2O2 treated cells to cells treated with 100 µg/mL vitamin A, it is possible to
observe an even more significant decrease (p < 0.0001) in the metabolic activity of the tumor cells.
Additionally, comparing the effect of 100 µg/mL vitamin A treatment in cells previously submitted to
25 µM H2O2, not only the buffering effect of 0.1 µg/mL vitamin A was not observed. Contrariwise, an
even lower metabolic activity was found (p < 0.0001) in melanoma cells than the metabolic activity
achieved with both treatments (25 µM H2O2 and 100 µg/mL vitamin A) alone.
3.3. LPS Is Capable of the Activation of RAW 264.7 Naïve Cells
For the assessment of macrophage cytotoxicity, RAW 264.7 cells were previously incubated with
1 µg/mL LPS. After 24 h, cells were also incubated with 0.1 and 100.0 µg/mL vitamin A concentrations.
Figure 3 shows the phenotype of RAW 264.7 cells before LPS treatment (Figure 3A), and after LPS
treatment (Figure 3B).
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Figure 3. RAW 264.7 macrophage-cells like before (A) and after (B) LPS treatment (200×).
Figure 3 shows the influence of LPS treatment on RAW 264.7 macrophage-like cells phenotype.
Macrophage-like cells without LPS activation presents a round shape morphology (Figure 3A), and
cells with LPS activation presents a macrophage-like shape with some pseudopods (Figure 3B).
3.4. The Percentage of Macrophage-Mediated Cells Cytotoxicity Is Inversely Correlated to Cell Culture Results
Alone
After LPS activation, two groups were treated with the two different concentrations of vitamin
A previously used. According to the cytotoxic algorithm created by Seo and collaborators [31], the
percentage of cytotoxicity mediated by macrophages was assessed in the conditions defined for the
present experiment. The results of this experiment are shown in Table 1.
Table 1. Percentage (%) of macrophage-mediated cells cytotoxicity.
Cells and Treatments Cytotoxicity (%)
Control (without vitamin A) 73.8%
Vitamin A treatment [0.1 µg/mL] 86.8%
Vitamin A treatment [100 µg/mL] 75.7%
4. Discussion
Despite all the knowledg about melanoma biology, this cancer remains one of the greatest
challenges f our day [1,5,32,33], mainly due to the acquired r sistanc to chemother y and
radiation [5,30]. Therefor , melanoma treatment r mains essentially surgical [1,6,7,10].
Although the diagnosis is relatively easy, there is an emerging need for new compounds capable
of preventive or curative properties. That way, there are growing fields that state the possible role of
dietary factors [1,11], as well as the immunostimulation by external compounds [31].
Emerging evidence indicates that dietary factors, such as antioxidant compounds, could have a
double role, acting as an antioxidant and pro-oxidant, depending on the concentrations used [34–36].
Some studies suggest that these compounds could be used in cancer prevention and/or treatment [37–39].
According to this line of evidence, Figures 1 and 2 show that H2O2 and vitamin A treatments alone
are capable of reducing cell metabolic activity in a significant way. When treatments are combined,
0.1 µg/mL vitamin A has the capability of an increase in cell metabolic activity that surpasses the
percentage of metabolic activity of H2O2 treatment alone (Figure 1). At this point, these data may
suggest a possible antioxidant role of lo er concentrations of vitamin A in melanoma cells. On the
other hand, when treatments a e combined, 100 µg/mL vitamin A has the capability of a dec ease in
metabolic ctivity that is l wer than H2O2 treatment alone (Figure 2). Accordingly, these data may
suggest a possible pro-oxidant role of higher concentrations of vitamin A. However, further studies are
needed to prove this possibility.
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These in vitro model experiments gave a pool of results that allows us to suggest that vitamin A
could have a possible double role, acting as an antioxidant and pro-oxidant, depending on the vitamin
A concentration used. In this manner, and in order to assess the effect of vitamin A in a more complex
environment, more experiments were done. For that, an immune response induction model was used
based on the work developed by Seo and collaborators [31].
The present model establishes a co-culture of both macrophages RAW 264.7 and B16-F10 melanoma
cells. Under basal conditions, when macrophages are activated with LPS, they are able to limit tumor
cells activity in a basal cytotoxic level of 73.8% (Table 1). This value is considered the baseline for this
experiment and every group previously submitted to LPS activation.
After LPS activation, two groups of macrophages were treated with different amounts of vitamin
A. Macrophages stimulated with 0.1 µg/mL vitamin A achieved a cytotoxicity of 86.8% (13% higher),
whereas 100 µg/mL vitamin A treatment presented a cytotoxicity of only 75.7%. Thus, activated
macrophages stimulated with 100 µg/mL vitamin A treatment presented a slight increased cytotoxicity
of only 1.9%.
These results show the capability of lower concentrations of vitamin A to increase the macrophage
activity more effectively than higher concentrations of vitamin A treatment, thus enhancing
macrophage-induced cytotoxicity.
If this work ended at the redox studies, one may suggest that vitamin A could have a possible
antitumor effect/role [34–36]. However, the co-culture experiment allowed the study of different
concentrations of vitamin A in a more complex environment. In this experiment, the possible
therapeutic effect of vitamin A was inversely correlated to the results of the melanoma cells culture
alone. According to these data, when the vitamin A dose is lower, its antitumor activity is enhanced
in a more efficient way, since macrophage-melanoma cells binomial shows a decrease of tumor cells
metabolic activity (Table 1).
5. Conclusions
The discussion of the effect of vitamins in the literature is almost inconclusive, since there are no
studies devoted to the investigation of the dose–response effect of those vitamins. Although these
results are encouraging, new questions are now evolving. Given that there is little information about
vitamin A and melanoma, further studies should be done in order to validate the results presented in
this study.
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